On January 14, 2021, at the Robertson House in Stevenage, UK, the NHS Vaccination Center photographed the Innova SARS-CoV-2 antigen test kit when the coronavirus disease (COVID-19) broke out. Leon Neal/Pool via REUTERS/File photo
London, June 17 (Reuters)-The UK drug regulator extended the emergency use approval (EUA) for Innova’s sidestream COVID-19 test on Thursday, saying it was satisfied with the review of the test following a warning from its US counterpart .
Innova’s test has been approved for asymptomatic testing as part of the testing and tracking system in England.
Last week, the U.S. Food and Drug Administration (FDA) urged the public to stop using the test, warning that its performance has not yet been fully established.
“We have now concluded the review of the risk assessment and are satisfied that no further action is necessary or recommended at this time,” said Graeme Tunbridge, head of equipment at the Medicines and Healthcare Products Regulatory Agency (MHRA).
British Prime Minister Boris Johnson said that regular asymptomatic testing plays an important role in reopening the economy. However, some scientists question the accuracy of the rapid tests used in the UK, saying they may do more harm than good. read more
The Department of Public Health of the United Kingdom stated that these tests have been rigorously validated and can help stop the outbreak by detecting undetected COVID-19 cases.
Subscribe to our daily featured newsletter to receive the latest exclusive Reuters reports sent to your inbox.
The main manufacturing center in Dongguan, Guangdong Province, China’s most populous province, launched a large-scale coronavirus test on Monday and blocked the community after detecting the first infection in the current epidemic.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people around the world every day. Reuters provides business, financial, domestic and international news directly to consumers through desktop terminals, world media organizations, industry events and directly.
Rely on authoritative content, lawyer editing expertise, and industry-defining technology to build the most powerful argument.
The most comprehensive solution to manage all complex and expanding tax and compliance needs.
Information, analysis and exclusive news about financial markets-available in an intuitive desktop and mobile interface.
Screen high-risk individuals and entities around the world to help discover hidden risks in business relationships and interpersonal relationships.
Post time: Jun-21-2021